OPK NASDAQ
OPKO Health, Inc.
1W: +16.4%
1M: +4.1%
3M: +6.7%
YTD: +0.8%
1Y: -3.8%
3Y: -21.0%
5Y: -65.4%
$1.27
-0.01 (-0.78%)
Weekly Expected Move ±5.1%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (38)
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y
This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
OPKO Health Q1 2026 Earnings Call: Complete Transcript
Opko outlines Q2 2026 revenue of $127M-$132M as ModeX advances 5 clinical programs
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
OPKO Health GAAP EPS of -$0.07 in-line, revenue of $124.2M misses by $6.57M
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
Here are the major earnings after the close Tuesday
Earnings Scheduled For April 28, 2026
Earnings week ahead: MSFT, AAPL, GOOG, AMZN, META, XOM, CVX, KO, V, SBUX, F, GM, and more
Here's Why You Should Hold OPK Stock in Your Portfolio for Now
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
Here's Why You Should Hold OPK Stock in Your Portfolio for Now
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript
Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics
OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Earnings week ahead: NVDA, CRM, HD, BIDU, LOW, DELL, SNOW, AMC, ZM, and more
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
Reviewing OPKO Health (NASDAQ:OPK) and Coloplast A/S (OTCMKTS:CLPBY)
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
OPKO Health: Deeply Mispriced Ahead Of Major Catalysts
OPKO Health (NASDAQ:OPK) Shares Cross Below Fifty Day Moving Average – Here’s Why
OPKO Health (NASDAQ:OPK) & Positron (OTCMKTS:POSC) Head-To-Head Review
OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth
Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference